## Diagnosis: Chlamydial Conjunctivitis (Inclusion Conjunctivitis) ### Clinical Presentation **Key Point:** A 6-week history of bilateral follicular conjunctivitis with intracellular inclusions on Giemsa stain is diagnostic of *Chlamydia trachomatis* infection (serovars D–K cause inclusion conjunctivitis; serovars L1–L3 cause lymphogranuloma venereum). ### Features of Chlamydial Conjunctivitis | Feature | Presentation | | --- | --- | | **Onset** | 5–14 days (subacute; slower than gonococcal) | | **Discharge** | Mucoid to mucopurulent (not copious purulent) | | **Lid findings** | Mild edema, recurrent swelling | | **Conjunctival signs** | Follicular reaction (especially upper tarsal), mild pannus | | **Systemic involvement** | Often asymptomatic; may have otitis media, pneumonia | | **Gram stain** | Gram-negative intracellular; often gram-negative | | **Giemsa stain** | Intracellular inclusions (basophilic, in cytoplasm) | | **Culture** | Difficult; requires cell culture or PCR | | **Duration untreated** | Weeks to months (chronic if untreated) | ### Treatment Algorithm ```mermaid flowchart TD A["Chlamydial conjunctivitis confirmed<br/>(Giemsa stain: inclusions)"]:::outcome --> B{"Age and pregnancy status?"}:::decision B -->|"Child > 1 month or adult<br/>(not pregnant)"|C["Oral azithromycin<br/>10 mg/kg/day × 3 days<br/>OR doxycycline 100 mg BD × 3 weeks"]:::action B -->|"Neonate or pregnant"|D["Oral erythromycin<br/>50 mg/kg/day × 3 weeks<br/>(avoid tetracyclines)"]:::action C --> E["Topical tetracycline ointment<br/>4× daily × 6 weeks"]:::action D --> F["Topical erythromycin ointment<br/>4× daily × 6 weeks"]:::action E --> G["Treat sexual partner(s)<br/>with same systemic regimen"]:::action F --> G G --> H["Follow-up at 3 weeks<br/>to confirm resolution"]:::outcome ``` **High-Yield:** Azithromycin 10 mg/kg/day for 3 days is now preferred over doxycycline in children because it is: - Shorter course (better compliance) - Safe in children (no tooth staining) - Effective against resistant strains ### Why Topical Therapy Alone Is Insufficient **Clinical Pearl:** *Chlamydia trachomatis* is an obligate intracellular pathogen. Topical antibiotics achieve only low concentrations within epithelial cells. Systemic therapy is essential to eradicate the organism and prevent relapse. **Mnemonic: CHLAMYDIA INCLUSION** — **C**hild with follicular reaction, **H**istory 5–14 days, **L**ower tarsal involvement, **A**cute to chronic course, **M**ucoid discharge, **Y**oung age, **D**iagnosis by Giemsa, **I**nclusional bodies, **A** — Always treat systemically. ### Neonatal Chlamydial Ophthalmia - Occurs at 5–14 days of age - Presents with purulent discharge, lid swelling, chemosis - Treatment: Oral erythromycin 50 mg/kg/day × 3 weeks (NOT topical alone) - Prevention: Erythromycin ointment at birth (though less effective than for gonorrhea) ### Differential Diagnosis Summary | Condition | Onset | Discharge | Inclusions | Treatment | | --- | --- | --- | --- | --- | | Chlamydial (D–K) | 5–14 days | Mucoid | Giemsa+ | Azithromycin + topical tetracycline | | Gonococcal | 2–5 days | Copious purulent | Gram stain: GN diplococci | Ceftriaxone + azithromycin | | Viral (adenovirus) | 1–3 days | Watery | None | Supportive care | | Allergic | Variable | Ropy mucus | None | Antihistamines, mast cell stabilizers | **Warning:** Do NOT use doxycycline in children < 8 years (risk of tooth discoloration and bone dysplasia). Azithromycin or erythromycin are safe alternatives. 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.